2026 IFSC | Professor Daichi Inoue Explores Clonal Evolution in Leukemia with Extremely Poor Prognosis: SETBP1 Abundance-Dependent Mechanisms and Early Intervention Strategies
Basic stem cell research, regenerative medicine, cell therapy, and the application of clinical research guidelines are currently among the most closely watched frontiers in global hematology and translational medicine. With these topics at its core, the 10th International Forum on Stem Cells (IFSC) was successfully held, bringing together leading experts and scholars from around the world to explore scientific discoveries and technological innovation. The forum showcased the latest advances in basic, clinical, and translational research on hematopoietic stem cells, with the aim of promoting collaborative innovation in the global stem cell field. During the conference, Oncology Frontier – Hematology Frontier invited Professor Daichi Inoue of Osaka University, Japan, to share his latest research findings and perspectives on "Clonal Evolution and Targeted Intervention in Leukemia with Extremely Poor Prognosis." The key insights are presented below.









